0001209191-16-136549.txt : 20160811
0001209191-16-136549.hdr.sgml : 20160811
20160811161159
ACCESSION NUMBER: 0001209191-16-136549
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160810
FILED AS OF DATE: 20160811
DATE AS OF CHANGE: 20160811
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 161824688
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-08-10
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2016-08-10
4
M
0
6500
36.30
A
274725
D
Common Stock
2016-08-10
4
S
0
4900
99.96
D
269825
D
Common Stock
2016-08-10
4
S
0
1600
100.93
D
268225
D
Common Stock
13286
I
401k
Common Stock
2016-08-10
4
S
0
400
100.38
D
81800
I
Common Stock Held In Trust
Common Stock
2016-08-10
4
S
0
200
101.34
D
81600
I
Common Stock Held In Trust
Stock Option (Right to Buy)
36.30
2016-08-10
4
M
0
6500
0.00
D
2017-01-23
Common Stock
6500
144500
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
The holder undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $99.96 (range $99.55 to $100.35).
Open market sales reported on this line occurred at a weighted average price of $100.93 (range $100.59 to $101.38).
Open market sales reported on this line occurred at a weighted average price of $100.38 (range $100.29 to $100.60).
Fully vested.
Omar White, Attorney-In-Fact
2016-08-11